Disease staging: CliniCal anD CoDeD Criteria - HCUP

Clinical Criteria with Description, Diagnostic Findings and ICD-9-CM codes
DXCat Number: TRA03
MultiStage: No
DXCat Label: Adverse Effects of Salicylates Specificity: A
Etiology: Toxicologic
Stage Description Diagnostic findings ICD-9-CM Codes
1.01 Salicylism Serum salicylate level ≥ 60 mg/dl ≤ 1 hour after ingestion
[chemistry report]
DX 9651, E9353;
OR toxic levels up to 48 hours post ingestion
[serum salicylate level ≥ {60 mg/dl - (hours post ingestion x1.25)}]
e.g., serum salicylate level of 56 four hours post ingestion is toxic: 60-(4x1.25) = 55
2.01 with respiratory alkalosis Stage 1.01
AND alkalosis:
AND hypocarbia:
2.02 with metabolic derangements or Stage 1.01-2.01
dehydration
AND dehydration:
OR hypernatremia:
OR hyperkalemia:
OR hypokalemia:
OR hyponatremia:
2.03 with acidosis Stage 1.01-2.02
AND acidosis:
2.04 with hemorrhagic gastritis or diathesis Stage 1.01-2.03
AND hemorrhagic gastritis [endoscopy report]
OR petechiae
OR bleeding time prolonged [bleeding time report]
OR INR > 1.5 [hematology report]
STAGE 1.01 + GROUP ALKALOSIS;
STAGE 1.01-2.01 + (GROUP
DEHYDRATION OR GROUP
HYPR_NATREM OR GROUP
HYPER_KALEM OR GROUP
HYPOKALEMIA OR GROUP
HYPONATREMIA);
STAGE 1.01-2.02 + GROUP
ACIDOSIS;
STAGE 1.01-2.03 + (DX 2879,
53501, 53551, 7827);
3.01 with renal failure Stage 1.01-2.03
AND renal failure:
3.02 with respiratory failure Stage 1.01-3.01
AND respiratory failure:
3.03 with coma Stage 1.01-3.02
AND coma:
3.04 with shock Stage 1.01-3.03
AND shock:
4.00 with death Stage 2.01-3.04
AND death
STAGE 1.01-2.04 + (GROUP
REN_FAIL_ACU OR GROUP
REN_FAIL_CHR);
STAGE 1.01-3.01 + GROUP
RESP_FAIL;
STAGE 1.01-3.02 + GROUP COMA;
STAGE 1.01-3.03 + (DX 9950, 9994
OR GROUP ARHTHYM_VFIB OR
GROUP SHOCKA);
NO;
Thursday, January 07, 2010 9:23:20 AM
©2010 Thomson Reuters. All rights reserved.